Dear Editor,

*Coprobacillus catenaformis* is a gram-positive, obligatorily anaerobic, non-spore-forming rod bacteria. In 2000, *Coprobacillus* gen. nov. (*Copro*, feces; *bacillus*, a small rod) *catenaformis* spp. nov. (*catena*, chain; *formis*, shaped) was proposed as a member of the *Clostridium* subphylum of gram-positive bacteria that is phylogenetically closely associated with *Clostridium ramosum* and *C. spiroforme* \[[@b1-alm-2020-40-5-421]\]. *C. catenaformis*, the only known species in the genus *Coprobacillus*, is a member of the intestinal microbiota of humans and mice, as shown by metagenomics studies \[[@b2-alm-2020-40-5-421], [@b3-alm-2020-40-5-421]\]. To the best of our knowledge, this species has not been isolated from clinical specimens, including blood cultures. We report the first case of bacteremia caused by *C. catenaformis*. The Institutional Review Board of Samsung Medical Center, Seoul, Korea, approved this study (approval number: 2020-03-085) and waived the need for informed consent.

A patient in her 60s, who received several cycles of chemotherapy and radiotherapy for non-small cell lung cancer with pleural and bone metastases since August 2014, was admitted to Samsung Medical Center in August 2019 for a decompressive laminectomy with pedicle screw fixation and tumor removal. On post-operative day 8, a bisacodyl enema was administered for \>10 days without defecation. A few hours after the enema, the patient complained of chilling sensation and had a body temperature of 38.6°C. Her blood pressure was 108/55 mm Hg, pulse rate was 142 bpm, and respiratory rate was 18 breaths per minute. Her C-reactive protein was 56.3 (reference interval, 0--5.0) mg/L and leukocyte count was 10.44×10^9^/L (neutrophils, 98.0%). After preparing two sets of aerobic and anaerobic blood culture bottles (bioMérieux, Marcy l'Etoile, France), empirical antibiotic therapy with intravenous piperacillin/tazobactam 4.5 g at eight hours interval was administered. On day 2 of incubation in a BacT/ALERT 3D blood culture instrument (bioMérieux), growth was observed in both anaerobic bottles of the two sets of blood cultures. Signal-positive bottles were subcultured and the following bacteria were isolated: *Eubacterium callanderi* and unidentified gram-positive bacilli from both sets of blood culture bottles and *Granulicatella elegans* from the blood culture bottle of the first set.

Microscopic examination revealed that the unidentified species was a gram-positive, non-spore-forming bacillus, which grew as small, grayish colonies on a Brucella agar plate ([Fig. 1](#f1-alm-2020-40-5-421){ref-type="fig"}). The microorganism could not be identified by matrix assisted laser desorption ionization-time of flights mass spectrometry using the VITEK-MS (bioMérieux) or the GP card of the VITEK 2 System (bioMérieux). To accurately identify the isolate, we performed 16S rRNA target sequencing using the universal primers described in the Clinical and Laboratory Standards Institute guidelines \[[@b4-alm-2020-40-5-421]\]. The amplified sequences were compared with sequences in the GenBank database using the basic local alignment search tool algorithm. The 16S rRNA sequence of the isolate exhibited 99.17% (715/721 bp) similarity with *C. catenaformis* (GenBank accession number AB030219.1). The second-best match was *Longibaculum muris*, with 92.18% (672/729 bp) similarity. When the sequence was submitted to the Ez-Taxon database (<http://www.ezbiocloud.net>), the best-matched strain was *C. catenaformis* (99.86%), which was accepted as the final confirmation of identity.

The patient was successfully treated with a 14-day course of intravenous piperacillin/tazobactam. Follow-up blood cultures from the peripheral veins on days 2, 5, and 14 were negative; the patient's condition improved and he/she was transferred to a long-term care facility.

To date, several studies have elucidated the roles of *Coprobacillus* species in the intestinal microbiota. In the human intestinal microbiota, the abundance of *Coprobacillus* increases with biological age \[[@b3-alm-2020-40-5-421]\] and is diminished in patients with multiple sclerosis \[[@b5-alm-2020-40-5-421]\]. In a mouse experiment, *Coprobacillus* played a role in inhibiting other microorganisms in the intestinal microbiota, including *Clostridioides difficile* \[[@b2-alm-2020-40-5-421]\]. To the best of our knowledge, this is the first case demonstrating the possibility of opportunistic *Coprobacillus* infections. Our patient had a polymicrobial bloodstream infection caused by *C. catenaformis*, *E. callanderi*, and *G. elegans*.

*Eubacterium* and *Granulicatella* species are present in the human mouth and intestinal tract and have been implicated as the cause of bacteremia \[[@b6-alm-2020-40-5-421]--[@b8-alm-2020-40-5-421]\]. The most common source of polymicrobial bloodstream infections is intra-abdominal infection \[[@b9-alm-2020-40-5-421]\]. The loss of intestinal barrier function contributes to systemic infection, and increased gut permeability is associated with the development of multi-organ dysfunction syndrome \[[@b10-alm-2020-40-5-421]\].

In conclusion, we report the first case of bacteremia caused by *Coprobacillus*. Although the information regarding human infections of *Coprobacillus* is limited, *Coprobacillus* should be considered a possible pathogen, especially in patients at high risk of gastrointestinal infections such as mechanical intestinal injury. Our report emphasizes the importance of *Coprobacillus* as a potential human pathogen.
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